C
ABMD

Cerebellum’s Abiomed Inc ABMD Stock Holding History

Cerebellum’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-679
Closed -$127K – 617
2020
Q2 		$127K Buy
+679
New +$136K 0.09% 219
2019
Q3 		– Sell
-1,347
Closed -$351K – 512
2019
Q2 		$351K Buy
1,347
+194
+17% +$51.5K 0.29% 137
2019
Q1 		$329K Buy
1,153
+349
+43% +$116K 0.29% 173
2018
Q4 		$261K Buy
+804
New +$279K 0.18% 94
2018
Q3 		– Sell
-369
Closed -$151K – 532
2018
Q2 		$151K Buy
+369
New +$134K 0.25% 320
2018
Q1 		– Sell
-679
Closed -$127K – 556
2017
Q4 		$127K Buy
+679
New +$127K 0.09% 219

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return